Literature DB >> 1782144

Hepatitis C in deceased drug addicts.

K Trübner1, S Polywka, K Püschel, R Laufs.   

Abstract

Needle sharing among drug addicts leads to the transmission of infectious diseases such as hepatitis B and AIDS. After development of a test system based on gene technology against the hepatitis C virus (HCV), drug addicts have been regarded as an important reservoir for hepatitis C. In our study 113 (40.1%) out of 282 addicts who died from drug abuse in Hamburg between 1988 and 1990 had antibodies against HCV (anti-HCV). The prevalence of anti-HCV differed in various age groups; the highest prevalence was found in addicts aged 30-34 years. Co-infections with hepatitis B and hepatitis C virus were found in 57 drug addicts (59.4%) out of 96 deceased with antibodies to hepatitis B (anti-HBc), whereas only 8 out of 23 HIV-infected were anti-HCV positive (34.8%).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1782144     DOI: 10.1007/bf01369579

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  14 in total

1.  Research seems to be gaining upper hand on what's been called non-A, non-B hepatitis.

Authors:  C Marwick; A Skolnick
Journal:  JAMA       Date:  1990-01-05       Impact factor: 56.272

2.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

Review 3.  [Hepatitis C virus (HCV), anti-HCV and non-A, non-B hepatitis].

Authors:  P J Grob; H J Joller-Jemelka
Journal:  Schweiz Med Wochenschr       Date:  1990-02-03

4.  Non-A, non-B hepatitis and antibody to hepatitis C virus.

Authors:  J W Mosley; R D Aach; F B Hollinger; C E Stevens; L H Barbosa; G J Nemo; P V Holland; W H Bancroft; H J Zimmerman; G Kuo
Journal:  JAMA       Date:  1990-01-05       Impact factor: 56.272

5.  Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.

Authors:  M Colombo; G Kuo; Q L Choo; M F Donato; E Del Ninno; M A Tommasini; N Dioguardi; M Houghton
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

6.  [Hepatitis in drug poisonings].

Authors:  K Trübner; K Püschel; R Laufs
Journal:  Z Rechtsmed       Date:  1989

7.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

8.  Hepatitis C virus antibodies among different groups at risk and patients with suspected non-A, non-B hepatitis.

Authors:  S Polywka; R Laufs
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

9.  Hepatitis C virus antibodies among risk groups in Spain.

Authors:  J I Esteban; R Esteban; L Viladomiu; J C López-Talavera; A González; J M Hernández; M Roget; V Vargas; J Genescà; M Buti
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more
  1 in total

1.  Surveillance of HIV and viral hepatitis by analysis of samples from drug related deaths.

Authors:  Peer Brehm Christensen; Birgitte Kringsholm; Jytte Banner; Jørgen L Thomsen; Susan Cowan; Gabriela Felicia Stein; Gitte Wulf Jürgensen; Kari Grasaasen; Jørgen Georgsen; Court Pedersen
Journal:  Eur J Epidemiol       Date:  2006-06-09       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.